Health and Healthcare
Healthways: The Implosion of the Day (HWAY, CI)
Published:
Last Updated:
Healthways Inc. (NASDAQ: HWAY) could be named “The Implosion Stock of the Day.” Revenues rose 3.3% from a year earlier to $176.2 million, but that sequential earnings gain is actually more than a 6% annual drop to $0.28 EPS. In raw dollars, the earnings drop was an even higher percentage. Healthways is a provider aimed at helping people maintain or improve their health and well-being to reduce overall healthcare costs.
What does one do when 65% sequential earnings growth is not enough? That is what investors can ask, although a contract loss is the biggest culprit for today’s implosion. Cigna Corporation (NYSE: CI) recently informed the company that it will wind down its current contract in 2012 ahead of the contract’s Feb-2013 expiration and that contract is expected to produce revenues of $110 to $115 million. Healthways expects a reduction in revenues from Cigna for 2012 compared with 2011 in a range of $60 million to $65 million. Ouch.
The company noted that its net operating cash flow was down from the prior two quarters to $9.4 million. The company did note that it continues to expect full-year net operating cash flow in a range of $80 million to $100 million. The company also affirmed its guidance for 2011 revenues of $672 to $710 million ($650 to $680 million domestic and $22 to $30 million international). The company also sees 2011 net income in a range of $0.90 to $1.00 EPS versus a previous range of $0.90 to $1.08 EPS.
Shares are down almost 35% around $7.40 in the pre-market and the prior 52-week trading range was $8.63 to $17.62.
JON C. OGG
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.